Exenatide biobetter(Biolingus)

N/A

Report date: 2025/08/12 17:29:19

Base Information

Drug NameExenatide biobetter(Biolingus)
Drug Alias NameExenatide biobetter (Vitapharm/Biolingus)Project A1 (OPUS)-BiolingusExenatide sublingual-BiolingusExenatide oral-Biolingus
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVitapharm Technology DevelopmentBiolingus
China Registration ClassN/A

Develop Information

Active CompaniesVitapharm Technology Development
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A